Viracta Therapeutics logo

Viracta Therapeutics share price today

(VIRX)

Viracta Therapeutics share price is $0.21 & ₹18.02 as on 7 Jan 2025, 2.30 'hrs' IST

$0.21

-0.01

(-4.62%)

Market is closed - opens 8 PM, 07 Jan 2025

View live Viracta Therapeutics share price in Dollar and Rupees. Guide to invest in Viracta Therapeutics stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Viracta Therapeutics, along with analyst recommendations, forecasts, and comprehensive financials.

Viracta Therapeutics share price movements

  • Today's Low: $0.19
    Today's High: $0.24

    Day's Volatility :21.27%

  • 52 Weeks Low: $0.13
    52 Weeks High: $1.31

    52 Weeks Volatility :89.96%

Viracta Therapeutics Returns

PeriodViracta Therapeutics IncSector (Health Care)Index (Russel 2000)
3 Months
-5.19%
-8.0%
0.0%
6 Months
-54.33%
-3.8%
0.0%
1 Year
-62.83%
-0.1%
0.0%
3 Years
-93.3%
3.4%
-18.8%

Viracta Therapeutics Key Statistics

in dollars & INR

Previous Close
$0.223
Open
$0.2052
Today's High
$0.237
Today's Low
$0.1866
Market Capitalization
$6.4M
Today's Volume
$10.9M
52 Week High
$1.31
52 Week Low
$0.1315
Revenue TTM
$0.0
EBITDA
$-49.0M
Earnings Per Share (EPS)
$-1.1
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-208.67%

How to invest in Viracta Therapeutics from India?

It is very easy for Indian residents to invest directly in Viracta Therapeutics from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Viracta Therapeutics stock in both Indian Rupees (INR) and US Dollars (USD). Search for Viracta Therapeutics or VIRX on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Viracta Therapeutics or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Viracta Therapeutics shares which would translate to 4.086 fractional shares of Viracta Therapeutics as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Viracta Therapeutics, in just a few clicks!

Returns in Viracta Therapeutics for Indian investors in Rupees

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Viracta Therapeutics investment value today

Current value as on today

₹38,214

Returns

₹61,786

(-61.79%)

Returns from Viracta Therapeutics Stock

₹65,000 (-65%)

Dollar Returns

₹3,214 (+3.21%)

Indian investors sentiment towards Viracta Therapeutics

866.67%

Period: Oct 8, 2024 to Jan 6, 2025. Change in 30 Days versus previous period

Investment in Viracta Therapeutics from India has grown in the last 30 days as on Jan 7, 2025. 866.67% more purchase transactions for Viracta Therapeutics in the last 30 days versus the previous period.

233%

Period: Oct 8, 2024 to Jan 6, 2025. Change in 30 Days versus previous period

Search volume for Viracta Therapeutics on INDmoney from India has grown in the last 30 days as on Jan 7, 2025. 233% more investors are searching Viracta Therapeutics in the last 30 days versus the previous period.

Global Institutional Holdings in Viracta Therapeutics

  • Citadel Advisors Llc

    3.83%

  • Vanguard Group Inc

    2.40%

  • Samsara BioCapital, LLC

    1.74%

  • Stonepine Capital Management Llc

    1.26%

  • LAURION CAPITAL MANAGEMENT LP

    0.84%

  • Aisling Capital Management LP

    0.73%

Analyst Recommendation on Viracta Therapeutics

Buy

    90%Buy

    10%Hold

    0%Sell

Based on 10 Wall street analysts offering stock ratings for Viracta Therapeutics(by analysts ranked 0 to 5 stars)

Based on 10 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
9
9
9
Hold
1
1
1
Sell
0
0
0

Analyst Forecast on Viracta Therapeutics

What analysts predicted

Upside of 1328.57%

Current:

$0.21

Target:

$3.00

Insights on Viracta Therapeutics

  • Price Movement

    In the last 7 days, VIRX stock has moved up by 38.6%
  • VIRX vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 23.7% return, outperforming this stock by 86.5%
  • VIRX vs VRTX (3 yr)

    In the last 3 years, Vertex Pharmaceuticals Incorporated has given 58.2% return, outperforming this stock by 151.5%

Viracta Therapeutics Technicals Summary

Sell

Neutral

Buy

Viracta Therapeutics is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

Viracta Therapeutics Vs Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Viracta Therapeutics Inc
28.01%
-54.33%
-62.83%
-93.3%
-98.58%
Regeneron Pharmaceuticals, Inc.
-8.86%
-31.87%
-20.46%
15.59%
87.28%
Biontech Se
-4.16%
43.82%
3.49%
-49.66%
167.6%
Alnylam Pharmaceuticals, Inc.
-8.45%
-8.03%
19.03%
56.02%
98.44%
Vertex Pharmaceuticals Incorporated
-14.11%
-16.23%
-2.87%
81.78%
76.8%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Viracta Therapeutics Inc
1.23
NA
NA
-0.9
-2.09
-0.57
NA
0.33
Regeneron Pharmaceuticals, Inc.
17.61
17.61
1.06
45.07
0.17
0.07
NA
272.04
Biontech Se
160.8
NA
0.04
-3.11
-0.02
-0.01
NA
79.73
Alnylam Pharmaceuticals, Inc.
NA
NA
-0.49
-0.19
-15.01
-0.03
NA
0.25
Vertex Pharmaceuticals Incorporated
32.84
NA
1.06
0.51
-0.03
0.12
NA
60.65
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Viracta Therapeutics Inc
Buy
$6.4M
-98.58%
1.23
0.0%
Regeneron Pharmaceuticals, Inc.
Buy
$78.3B
87.28%
17.61
33.61%
Biontech Se
Buy
$27.3B
167.6%
160.8
-15.36%
Alnylam Pharmaceuticals, Inc.
Buy
$30.4B
98.44%
NA
-15.86%
Vertex Pharmaceuticals Incorporated
Buy
$103.7B
76.8%
32.84
-4.51%

About Viracta Therapeutics

viracta is focused on advancing a proprietary viral gene activation therapy to address cancers associated with the epstein-barr virus, and will pursue opportunities to address other serious virus-associated disease.
Organization
Viracta Therapeutics
Employees
40
CEO
Mr. Mark Andrew Rothera
Industry
Healthcare

Management People of Viracta Therapeutics

NameTitle
Mr. Mark Andrew Rothera
CEO, President & Director
Dr. Darrel P. Cohen M.D., Ph.D.
Chief Medical Officer
Dr. Susan Perrine M.D.
Scientific Founder and Consultant
Dr. Ronald J. Berenson M.D.
Co-Founder and Consultant
Mr. George Hillman
Co-Founder
Dr. Thalia Papayannopoulou M.D.
Co-Founder
Dr. Robert M. Williams Ph.D.
Co-Founder
Dr. Douglas V. Faller M.D., Ph.D.
Scientific Founder & Chairman of Scientific Advisory Board
Mr. Michael Eric Faerm
Chief Financial Officer
Dr. Ayman El-Guindy
Chief Scientific Officer

Important FAQs about investing in Viracta Therapeutics from India :

What is Viracta Therapeutics share price today?

Viracta Therapeutics share price today stands at $0.21, Open: $0.21 ; Previous Close: $0.22 ; High: $0.24 ; Low: $0.19 ; 52 Week High: $1.31 ; 52 Week Low: $0.13. The stock opens at $0.21, after a previous close of $0.22. The stock reached a daily high of $0.24 and a low of $0.19, with a 52-week high of $1.31 and a 52-week low of $0.13.

Can Indians buy Viracta Therapeutics shares?

Yes, Indians can invest in the Viracta Therapeutics (VIRX) from India.

With INDmoney, you can buy Viracta Therapeutics at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Viracta Therapeutics at zero transaction cost.

How can I buy Viracta Therapeutics shares from India?

It is very easy to buy Viracta Therapeutics from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Viracta Therapeutics be purchased?

Yes, you can buy fractional shares of Viracta Therapeutics with INDmoney app.

What are the documents required to start investing in Viracta Therapeutics stocks?

To start investing in Viracta Therapeutics, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Viracta Therapeutics

Today’s highest price of Viracta Therapeutics (VIRX) is $0.24.

Today’s lowest price of Viracta Therapeutics (VIRX) is $0.19.

What is today's market capitalisation of Viracta Therapeutics

Today's market capitalisation of Viracta Therapeutics VIRX is 6.4M

What is the 52 Week High and Low Range of Viracta Therapeutics

  • 52 Week High

    $1.31

  • 52 Week Low

    $0.13

What are the historical returns of Viracta Therapeutics?

  • 1 Month Returns

    28.01%

  • 3 Months Returns

    -54.33%

  • 1 Year Returns

    -62.83%

  • 5 Years Returns

    -98.58%

Who is the Chief Executive Officer (CEO) of Viracta Therapeutics

Mr. Mark Andrew Rothera is the current Chief Executive Officer (CEO) of Viracta Therapeutics.